SARS-CoV-2 Omicron variant
SARS-CoV-2 Omicron variant is a variant of the SARS-CoV-2 virus, which is responsible for the COVID-19 pandemic. It was first identified in Botswana in November 2021 and was subsequently designated as a variant of concern by the World Health Organization (WHO) due to its large number of mutations and potential implications for global public health.
Origin and identification
The Omicron variant was first identified through genomic sequencing in Botswana in November 2021. It was subsequently reported to the WHO, which designated it as a variant of concern on 26 November 2021. The variant has been named 'Omicron' as per the WHO's policy of naming variants after letters of the Greek alphabet.
Characteristics
The Omicron variant is characterized by a large number of mutations, particularly in the spike protein of the virus, which is the target of most COVID-19 vaccines. Preliminary studies suggest that these mutations may increase the transmissibility of the virus and potentially affect the efficacy of vaccines, although further research is needed to confirm these findings.
Impact
The emergence of the Omicron variant has led to increased concern among global health authorities due to its potential to spread rapidly and evade immunity from vaccination or previous infection. However, it is currently unclear whether the variant is associated with more severe disease or increased mortality.
Response
In response to the emergence of the Omicron variant, many countries have implemented travel restrictions and increased surveillance and testing efforts. Vaccine manufacturers are also studying the variant and assessing the need for updated vaccines.
See also
Lua error in package.lua at line 80: module 'strict' not found.
SARS-CoV-2 Omicron variant
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD